
Field Medical Alignment Director (FMAD), Oncology
Merck
Summary
The US Oncology Medical Affairs Field Medical Alignment Director plays a critical leadership role in advancing the strategic priorities of US Medical Affairs across a dynamic and growing Oncology portfolio. This role is a key member of the Oncology/GI US Medical Affairs Leadership Teams and leverages scientific acumen and expertise within a disease state/tumor type to drive alignment, innovation, and execution across the oncology ecosystem.
Job description
Role Summary
The US Oncology Medical Affairs Field Medical Alignment Director plays a critical leadership role in advancing the strategic priorities of US Medical Affairs across a dynamic and growing Oncology portfolio. This role is a key member of the Oncology/GI US Medical Affairs Leadership Teams and leverages scientific acumen and expertise within a disease state/tumor type to drive alignment, innovation, and execution across the oncology ecosystem.
Strategic Planning and Execution Leadership
- Influence field medical execution to strategy planning through collaboration with Executive Directors, Team Leads, Payor Health Systems PASLs, SaMIs and US Directors of Medical Affairs to ensure strategic prioritization, implementation, and execution of US Medical Affairs Goals/Objectives and Country Medical Affairs Plans.
- Represent US TA Medical Affairs at departmental or cross-functional meetings impacting the full TA teams to ensure appropriate resource allocation, alignment and planning and execution excellence.
- Develop and lead implementation strategies throughout product life cycles and maximize synergies across programs and Scientific Leaders to deliver on Enterprise and Country strategic imperatives/goals.
- Support team value creation by identifying areas of high impact and translating into messaging via executive presentations that resonate with senior leadership.
- Continuously scan the healthcare environment and analyze emerging trends to determine individual skills and competencies to drive future organizational capabilities.
- Partner with leadership on culture-shaping initiatives, team development, and performance enablement to ensure a high-performing, innovative, and agile medical organization.
- Provide and leverage scientific and MA expert knowledge, innovative thinking and resources to assist in high-priority projects and critical departmental/team remits.
Operational Excellence
- Serve as the primary Oncology US Medical Affairs point of contact for operational and logistical stakeholders for aspects impacting the full TA team.
- Drive simplification, innovation, efficiency and effectiveness across medical systems, tools, and processes to increase agility and measurable outcomes.
- Exhibit expert understanding of company and organizational policies and procedures and be a resource for team.
- Provide strategic leadership to the Digital Innovation, Operations, and Compliance Council, including sites and systems of records for information input and data analysis.
- Develop and assess team data and analytics via dashboards, scorecards, and other analytics systems to track performance against team goals and impact metrics.
- Identify strategic opportunities to embed an AI-first mindset within Oncology.
- Strategically inform Country TA Leadership Team of gaps and/or opportunities to enhance processes and systems for Country TA Field Medical Affairs.
Requirements
- Advanced healthcare/science doctoral degree (e.g., M.D., Pharm.D., Ph.D.)
- At least 5 years field/medical affairs experience
- Minimum of 2 years in a HQ role or equivalent
- Minimum of 3 years working in oncology in the relevant therapeutic area
- Excellent interpersonal, analytical, strategic, tactical planning, project leadership and communication skills
- Ability to handle a demanding and changing workload and respond efficiently to timelines and changing market events
- Ability to work across a portfolio along the product life cycle
- Ability to effectively communicate information to internal and external stakeholders at all levels
- Business acumen with a superior understanding of the pharmaceutical industry and healthcare arena
- Proven ability to work with cross-functional highly matrixed teams and collaborate across multiple stakeholder groups
- Proven track record of contribution to medical and scientific development strategies within the pharmaceutical industry
- Full proficiency in Microsoft Suite (Excel, PPT, Word, etc.)
- Understanding of the capabilities of AI and its potential application to field medical effectiveness
- Scientific acumen and experience in gastrointestinal (GI) cancers
- Working knowledge of solid tumors, Immuno-Oncology, ADCs, targeted therapies
- MBA a plus
- Strategy lead and/or additional experience in a strategy and operations type role, including experience working in managed care/health systems
- Previous people or functional leadership, requiring executive-level presentations, creating communications for impact/action, and highly-matrixed, cross functional orgs
Benefits
- Medical, Dental & Vision
- Retirement Benefits
- 401(k)
- Paid Holidays
- Vacation
- Compassionate Leave
- Sick Days
- Annual Bonus
- Long-Term Incentive
Company overview
Merck & Co., Inc., known as Merck in the United States and Canada and MSD (Merck Sharp & Dohme) internationally, is a premier American multinational pharmaceutical company headquartered in Rahway, New Jersey. Founded in 1891 as the U.S. subsidiary of the German Merck Group, the company became independent following World War I and has since grown into one of the world's largest biomedical companies, ranking fourth globally by revenue. Merck operates across three core business segments: pharmaceuticals, vaccines, and animal health products. The company is renowned for its groundbreaking research and development, having brought numerous life-saving medicines to market including Keytruda (pembrolizumab), a leading immunotherapy for cancer treatment that generated $29.5 billion in 2024 revenue, and Gardasil, a revolutionary HPV vaccine. With approximately 75,000 employees worldwide, Merck maintains a robust pipeline of innovative therapies focused on oncology, vaccines, hospital acute care, cardiology, neuroscience, virology, immunology, and diabetes. The company invests heavily in R&D, spending $17.9 billion in 2024 alone, demonstrating its commitment to advancing scientific discovery. Merck's legacy spans over 130 years of bringing hope to humanity through important medicines and vaccines, operating with a purpose to use leading-edge science to save and improve lives globally while fostering an inclusive workforce and responsible business practices.